Nathan Bass, MD, PhD
Research Interests
My research focuses on clinical and translational studies of nonalcoholic fatty liver disease, complications of end-stage liver disease and hepatocellular carcinoma. I am site director for the NIH-funded NASH Clinical Research Network, in which one local project addresses the genomic basis of nonalcoholic fatty liver disease. In concert with other multi-center groups, we are conducting therapeutic trials of pharmacological agents in patients with complications of cirrhosis including portal hypertension and hepatic encephalopathy.
Selected Publications
- Kadayifdci A, Merriman, RA, Ferrell L, Bass, NM. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other etiologies. Journal of Hepatology 2008;49:595-599.
- Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology. 2008;47:1158-1166.
- Campos GM, Bambha K, Vittinghoff E, Rabl C, Posselt AM, Ciovica R, Tiwari U, Ferrell L, Pabst M, Bass NM, Merriman RB. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology 2008;47:1916-1923.
- David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB, Nonalcoholic Steatohepatitis Clinical Research Network. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:1904-1912.
- Professor
- Medicine/Gastroenterology
Research Theme
-
Pathophysiology, Clinical Epidemiology and Treatment of Complications of Cirrhosis Nonalcoholic Fatty Liver Disease
Contact Information
- Nathan.bass@
ucsf.edu - Phone: (415) 476-6424
- Fax: (415) 476-0659
- 513 Parnassus Ave.
- Box 0538, S-357
- San Francisco, CA. 94143-0538